Improvement of hepatic fibrosis and patient-reported outcomes in non-alcoholic steatohepatitis treated with selonsertib-Reference-Cited by-同舟云学术

Improvement of hepatic fibrosis and patient-reported outcomes in non-alcoholic steatohepatitis treated with selonsertib

Published:2018-02-22 Issue:10 Volume:38 Page:1849-1859
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Younossi Zobair M.¹^ORCID,Stepanova Maria²,Lawitz Eric³,Charlton Michael⁴,Loomba Rohit⁵,Myers Robert P.⁶,Subramanian Mani⁶,McHutchison John G.⁶,Goodman Zachary⁷

Affiliation:

1. Department of Medicine; Center for Liver Diseases; Inova Fairfax Hospital; Falls Church VA USA

2. Center for Outcomes Research in Liver Diseases; Washington DC USA

3. Texas Liver Institute; San Antonio TX USA

4. Intermountain Medical Center; Salt Lake City UT USA

5. University of California San Diego; La Jolla CA USA

6. Gilead Sciences, Inc.; Foster City CA USA

7. Betty and Guy Beatty Center for Integrated Research; Inova Health System; Falls Church VA USA

Funder

Gilead Sciences

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/liv.13706/fullpdf

Reference34 articles.

1. The Diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American association for the study of liver diseases;Chalasani;Hepatology,2018

2. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes;Younossi;Hepatology,2016

3. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults;Vernon;Aliment Pharmacol Ther,2011

4. Nonalcoholic steatofibrosis independently predicts mortality in nonalcoholic fatty liver disease;Younossi;Hepatol Commun,2017

5. Increased risk of mortality by fibrosis stage in non-alcoholic fatty liver disease: systematic review and meta-analysis;Dulai;Hepatology,2017

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the potential of drug repurposing for liver diseases: A comprehensive study;Life Sciences;2024-06

2. Assessment of fatigue and its impact in chronic liver disease;Journal of Hepatology;2024-04

3. Digital pathology with artificial intelligence analysis provides insight to the efficacy of anti-fibrotic compounds in human 3D MASH model;Scientific Reports;2024-03-11

4. Small-molecule inhibitors targeting apoptosis signal-regulated kinase 1;European Journal of Medicinal Chemistry;2023-12

5. Economic Burden and Patient-Reported Outcomes of Nonalcoholic Fatty Liver Disease;Clinics in Liver Disease;2023-05